News about Biotechnology

Belief Pharmaceuticals Group Has Announced that its Gene Therapy BM-H901 Injection Has Received Approval from the Macau

Belief Pharmaceuticals Group has announced that its gene therapy BM-H901 injection (generic name: Popedacoq injection) has received approval from the Macau Drug Administration for treating adult patients with moderate to severe haemophilia B (congenital factor IX deficiency).

Biotechnology | 22/03/2026 | By Darshana |  165

GI Innovation, Johnson & Johnson Partner for Phase Ib Trial in Advanced Prostate Cancer

GI Innovation enters clinical supply agreement with Johnson & Johnson to evaluate GI-102 and pasritamig combination therapy in metastatic castration-resistant prostate cancer patients.

Biotechnology | 21/03/2026 | By News Bureau |  200

Zydus Lifesciences Launches Aerolife Mini, India's First Portable Foldable Spacer

Zydus introduces Aerolife Mini, a compact pMDI enhancer designed to improve inhaler drug delivery and patient compliance in respiratory care through a convenient, foldable design.

Biotechnology | 20/03/2026 | By News Bureau |  218

Samsung Bioepis Partners with Sandoz for Next-Gen Biosimilar Candidates

Samsung Bioepis has partnered with Sandoz to develop and commercialise up to five biosimilar candidates, including SB36 (vedolizumab), across global markets, excluding select Asian regions, strengthening its pipeline in immunology and oncology.

Biotechnology | 19/03/2026 | By News Bureau |  184

Aplagon Doses First Patient in Phase IIa Trial of APAC for Chronic Limb-Threatening Ischemia

Aplagon has dosed the first patient in its Phase IIa HEALING trial evaluating APAC therapy for Chronic Limb?Threatening Ischemia caused by Peripheral Arterial Occlusive Disease in Finland.

Biotechnology | 16/03/2026 | By News Bureau |  181

WHO Unveils Three Product Profiles For Next-Generation Antibiotics

The World Health Organization has released three new Target Product Profiles (TPPs) aimed at guiding the development of antibacterial medicines to combat drug-resistant bacteria responsible for severe infections such as bloodstream infections, pneumonia, urinary tract infections and meningitis.

Biotechnology | 12/03/2026 | By Darshana |  295

National Institute for Health and Care Research Launches First Tessa Jowell AHP Research Fellowships for Brain Tumour Care

National Institute for Health and Care Research announces first Tessa Jowell AHP Research Fellows to advance neuro-oncology research, addressing rehabilitation and supportive care gaps for brain tumour patients across the United Kingdom.

Biotechnology | 10/03/2026 | By News Bureau |  122

PureHealth Research Launches Botanical GLP-1 Supplements to Support Natural Metabolic Health

PureHealth Research introduces a new range of plant-based GLP-1 supplements formulated with clinically studied botanicals to naturally support satiety signaling, metabolic wellness, and healthy blood sugar levels.

Biotechnology | 09/03/2026 | By News Bureau |  229

Biologos Appoints Hetal Patel as Chief Executive Officer

Biologos, a leading ISO 13485–certified and GMP-compliant manufacturer of custom sterile-filtered liquid solutions, announced the appointment of Hetal Patel as chief executive officer.

Biotechnology | 07/03/2026 | By Darshana |  210

Antengene Licenses ATG-201 to UCB in Deal Worth Up to USD 1.1 Billion for Autoimmune Disease Therapy

Antengene grants UCB exclusive global rights to develop and commercialise ATG-201, a CD19/CD3 bispecific T-cell engager targeting autoimmune diseases, in a deal worth over USD 1.1 billion in milestones and royalties.

Biotechnology | 06/03/2026 | By News Bureau |  244